O2-06-03 Inflammatory biomarkers are associated with total brain volume: The Framingham Heart Study
暂无分享,去创建一个
P. Wolf | E. Benjamin | C. Decarli | S. Kathiresan | J. Meigs | J. Massaro | R. Au | M. Larson | S. Seshadri | J. Keaney | A. Jefferson | V. Ramachandran | Joseph M. Massaro
[1] D. Levy,et al. Contribution of Clinical Correlates and 13 C-Reactive Protein Gene Polymorphisms to Interindividual Variability in Serum C-Reactive Protein Level , 2006, Circulation.
[2] C. Jack,et al. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI , 2005, Neurology.
[3] J. Hirschhorn,et al. CCL2 Polymorphisms Are Associated With Serum Monocyte Chemoattractant Protein-1 Levels and Myocardial Infarction in the Framingham Heart Study , 2005, Circulation.
[4] A Hofman,et al. C-Reactive Protein and Cerebral Small-Vessel Disease: The Rotterdam Scan Study , 2005, Circulation.
[5] S. Kritchevsky,et al. Inflammatory markers and cardiovascular health in older adults. , 2005, Cardiovascular research.
[6] D. Harvey,et al. Measures of brain morphology and infarction in the framingham heart study: establishing what is normal , 2005, Neurobiology of Aging.
[7] R B D'Agostino,et al. Stroke risk profile, brain volume, and cognitive function , 2004, Neurology.
[8] Charles DeCarli,et al. Stroke Risk Profile Predicts White Matter Hyperintensity Volume: The Framingham Study , 2004, Stroke.
[9] E. Benjamin,et al. Heritability and correlates of intercellular adhesion molecule-1 in the Framingham Offspring Study. , 2004, Journal of the American College of Cardiology.
[10] A. D'Angelo,et al. Plasma osteoprotegerin as a biochemical marker for vascular dementia and Alzheimer's disease. , 2004, International journal of molecular medicine.
[11] A. Hofman,et al. Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. , 2004, Archives of neurology.
[12] C. Jack,et al. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD , 2004, Neurology.
[13] Patrick L. McGeer,et al. Inflammatory processes in Alzheimer's disease , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[14] A. Hofman,et al. Silent Brain Infarcts and White Matter Lesions Increase Stroke Risk in the General Population: The Rotterdam Scan Study , 2003, Stroke.
[15] M. Tullberg,et al. Correlation between Intrathecal Sulfatide and TNF-α Levels in Patients with Vascular Dementia , 2003, Dementia and Geriatric Cognitive Disorders.
[16] P. Libby,et al. Inflammation and Atherosclerosis , 2002, Circulation.
[17] Patrick L. McGeer,et al. Inflammation, autotoxicity and Alzheimer disease , 2001, Neurobiology of Aging.
[18] P. Mcgeer,et al. Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer’s disease , 2000, Brain Research.
[19] Jean-Philippe Galons,et al. Quantitative Volumetric Analyses of Brain Magnetic Resonance Imaging from Rat with Chronic Neuroinflammation , 2000, Experimental Neurology.
[20] C. Jack,et al. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD , 2000, Neurology.
[21] R. Killiany,et al. Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease , 2000, Annals of neurology.
[22] M N Rossor,et al. Correlation between rates of brain atrophy and cognitive decline in AD , 1999, Neurology.
[23] C. DeCarli,et al. Predictors of brain morphology for the men of the NHLBI twin study. , 1999, Stroke.
[24] S. Ekholm,et al. Intrathecal release of pro‐ and anti‐inflammatory cytokines during stroke , 1997, Clinical and experimental immunology.
[25] Nick C Fox,et al. Brain atrophy progression measured from registered serial MRI: Validation and application to alzheimer's disease , 1997, Journal of magnetic resonance imaging : JMRI.
[26] Nick C. Fox,et al. The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI , 1997, IEEE Transactions on Medical Imaging.
[27] Nick C Fox,et al. Visualisation and quantification of rates of atrophy in Alzheimer's disease , 1996, The Lancet.
[28] P. Pietrini,et al. Sex differences in human brain morphometry and metabolism: an in vivo quantitative magnetic resonance imaging and positron emission tomography study on the effect of aging. , 1996, Archives of general psychiatry.
[29] D. Teichberg,et al. Local histogram correction of MRI spatially dependent image pixel intensity nonuniformity , 1996, Journal of magnetic resonance imaging : JMRI.
[30] S. Ekholm,et al. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. , 1995, Stroke.
[31] Barry Horwitz,et al. Discriminant analysis of MRI measures as a method to determine the presence of dementia of the Alzheimer type , 1995, Psychiatry Research.
[32] J. Haxby,et al. Lack of age-related differences in temporal lobe volume of very healthy adults. , 1994, AJNR. American journal of neuroradiology.
[33] B. Horwitz,et al. Method for quantification of brain, ventricular, and subarachnoid CSF volumes from MR images. , 1992, Journal of computer assisted tomography.
[34] R B D'Agostino,et al. Probability of stroke: a risk profile from the Framingham Study. , 1991, Stroke.